$1.17
0.00%
Nasdaq, Aug 30, 01:15 am CET
ISIN
US00166B1052
Symbol
ALXO

Alx Oncology Holdings Inc Stock price

$1.17
+0.59 101.72% 1M
+0.07 6.36% 6M
-0.50 29.94% YTD
-1.13 49.13% 1Y
-12.13 91.20% 3Y
-39.27 97.11% 5Y
-28.83 96.10% 10Y
-28.83 96.10% 20Y
Nasdaq, Closing price Fri, Aug 29 2025
+0.03 2.63%
ISIN
US00166B1052
Symbol
ALXO
Industry

Key metrics

Basic
Market capitalization
$62.7m
Enterprise Value
$-4.4m
Net debt
positive
Cash
$79.3m
Shares outstanding
53.5m
Valuation (TTM | estimate)
P/E
negative | negative
P/S
- | -
EV/Sales
- | -
EV/FCF
0.0
P/B
1.0
Financial Health
Equity Ratio
77.0%
Return on Equity
-118.4%
ROCE
-154.9%
ROIC
-
Debt/Equity
0.2
Financials (TTM | estimate)
Revenue
$0.0 | $0.0
EBITDA
$-117.6m | $-81.7m
EBIT
$-118.5m | $-93.1m
Net Income
$-116.6m | $-92.1m
Free Cash Flow
$-106.3m
Growth (TTM | estimate)
Revenue
- | -
EBITDA
34.8% | 42.1%
EBIT
34.7% | 34.4%
Net Income
32.0% | 31.8%
Free Cash Flow
20.6%
Margin (TTM | estimate)
Gross
-
EBITDA
- | -
EBIT
-
Net
- | -
Free Cash Flow
-
More
EPS
$-2.2
FCF per Share
$-2.0
Short interest
4.9%
Employees
49
Rev per Employee
$0.0
Show more

Is Alx Oncology Holdings Inc a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,011 stocks worldwide.

Alx Oncology Holdings Inc Stock Analysis

Unlock Scores for Free

Analyst Opinions

12 Analysts have issued a Alx Oncology Holdings Inc forecast:

10x Buy
83%
2x Hold
17%

Analyst Opinions

12 Analysts have issued a Alx Oncology Holdings Inc forecast:

Buy
83%
Hold
17%

Financial data from Alx Oncology Holdings Inc

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
- -
-
100%
- Direct Costs - -
-
-
- -
-
-
- Selling and Administrative Expenses 27 27
0% 0%
-
- Research and Development Expense 92 92
40% 40%
-
-118 -118
35% 35%
-
- Depreciation and Amortization 0.84 0.84
1% 1%
-
EBIT (Operating Income) EBIT -118 -118
35% 35%
-
Net Profit -117 -117
32% 32%
-

In millions USD.

Don't miss a Thing! We will send you all news about Alx Oncology Holdings Inc directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Alx Oncology Holdings Inc Stock News

Neutral
GlobeNewsWire
3 days ago
SOUTH SAN FRANCISCO, Calif., Aug. 29, 2025 (GLOBE NEWSWIRE) -- ALX Oncology Holdings Inc., ("ALX Oncology" or the "Company") (Nasdaq: ALXO), a clinical-stage biotechnology company advancing a pipeline of novel therapies designed to treat cancer and extend patients' lives, today announced that ALX Oncology leadership will participate in both the Cantor Global Healthcare Conference 2025 and H.C. ...
Neutral
GlobeNewsWire
13 days ago
- A potential best- and first-in-class antibody-drug conjugate (ADC) for the treatment of EGFR-expressing solid tumors, ALX2004 is uniquely designed with every component optimized to maximize the therapeutic window -First-in-human trial of ALX2004 builds upon body of positive preclinical data demonstrating dose dependent anti-tumor activity and favorable safety profile -Initial safety data anti...
Neutral
Seeking Alpha
20 days ago
ALX Oncology Holdings Inc. (NASDAQ:ALXO ) Q2 2025 Earnings Conference Call August 12, 2023 4:30 AM ET Company Participants Alan Bart Sandler - Chief Medical Officer Harish Shantharam - Chief Financial Officer Jason W. Lettmann - CEO & Director Conference Call Participants Allison Marie Bratzel - Piper Sandler & Co., Research Division Li Wang Watsek - Cantor Fitzgerald & Co., Research Division R...
More Alx Oncology Holdings Inc News

Company Profile

ALX Oncology Holdings, Inc. operates as a clinical stage company, which engages in the research and development of therapies for cancer patients. Its objective is to provide clinical therapies for the treatment of myelodysplastic syndromes, acute myeloid leukemia, and a range of solid tumor indications. The company was founded by Corey Goodman, Jaume Pons, and K. Christopher Garcia on April 1, 2020 and is headquartered in Burlingame, CA.

Head office United States
CEO Jason Lettmann
Employees 49
Founded 2015
Website alxoncology.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today